Manufacturer record
Lark Laboratories (India) Ltd. Post Bag No.23 New Delhi- 110020: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Lark Laboratories (India) Ltd. Post Bag No.23 New Delhi- 110020 (Rajasthan) was declared Not of Standard Quality in February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: LXS3-49, Cefixime Oral Suspension IP (exp Oct 2026). RDTL, Guwahati (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per I.P. 2022 with respect to the test for Assay of Cefixime (asTrihydrate) equivalent to Cefixime. Listed in the February 2026 alert.
Records by type
1 record linked to Lark Laboratories (India) Ltd. Post Bag No.23 New Delhi- 110020 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cefixime Oral Suspension IP | Batch LXS3-49Mfg Nov 2024 · Exp Oct 2026 | The sample does not conform to claim as per I.P. 2022 with respect to the test for Assay of Cefixime (asTrihydrate) equivalent to Cefixime.Assay | RDTL, GuwahatiCDSCO lab | Feb 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.